Sheng Gong

6PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 19, 2025
Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1α/HIF2α regulation.

Pan Wang, Bin Liao, Sheng Gong

|Jun 30, 2023
MiR-146a-5p deficiency in extracellular vesicles of glioma-associated macrophages promotes epithelial-mesenchymal transition through the NF-κB signaling pathway.

Chao Xu, Pan Wang, Haiyan Guo

|May 14, 2021
Hyperbaric oxygen promotes not only glioblastoma proliferation but also chemosensitization by inhibiting HIF1α/HIF2α-Sox2.

Pan Wang, Sheng Gong, Jinyu Pan

|Mar 25, 2021
HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia.

Pan Wang, Lu Zhao, Sheng Gong

|Nov 19, 2020
The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions.

Pan Wang, Qian Yan, Bin Liao

|Feb 10, 2017
Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer.

Pan Wang, Wen-Wu Wan, Shuang-Long Xiong

Pageof 1

Frequent Collaborators